Results 221 to 230 of about 173,203 (312)

Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug‐Induced Liver Injury

Hepatology Research, EarlyView.
Three metabolites, pyroglutamylglycine (pyroGluGly), phenylalanine (Phe), and phenylalanyltryptophan (PheTrp), were identified as candidate DILI biomarkers. The serum concentrations of pyroGluGly, Phe, and PheTrp demonstrated a high differentiating ability in patients with mixed and cholestatic DILI compared with those in patients who recovered from ...
Kosuke Saito, Tatehiro Kagawa, Keiji Tsuji, Yuji Kumagai, Ken Sato, Shotaro Sakisaka, Naoya Sakamoto, Mitsuhiko Aiso, Shunji Hirose, Nami Mori, Toshio Uraoka, Kazuhide Takata, Koji Ogawa, Kazuhiko Mori, Motonobu Sato, Takayoshi Nishiya, Kazuhiko Takamatsu, Noriaki Arakawa, Takashi Izumi, Ruri Kikura‐Hanajiri, Yasuo Ohno, Yoshiro Saito, Hajime Takikawa   +22 more
wiley   +1 more source

Major Depression as a Catalyst for Nonalcoholic Fatty Liver Disease: Insights From a Comprehensive Mendelian Randomization Study. [PDF]

Can J Gastroenterol Hepatol
Su Y, Lin S, She L, Xiong J, Ding Y, Zhang Y, Chen Y.   +6 more
europepmc   +1 more source

Metabolic Health Phenotypes Among Middle‐ to Older‐Aged Adults Living With and Without Obesity: Relationships With Hepatic Health Indicators

Hepatology Research, EarlyView.
We examined liver health indicators among obese and nonobese metabolic health phenotypes. In fully adjusted models, higher fatty liver index (FLI) scores and liver enzyme concentrations of gamma‐glutamyl transferase (GGT) and alanine aminotransferase (ALT) were associated with lower likelihood of metabolically healthy obese (MHO) and nonobese (MHNO ...
Grainne Dolan, Seán R. Millar, Ivan J. Perry, Catherine M. Phillips   +3 more
wiley   +1 more source

Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease. [PDF]

Open Med (Wars)
Yu H, Wan M, Li H, Liu X.
europepmc   +1 more source

Metabolic traits as mediators between excess salt intake and the risk of nonalcoholic fatty liver disease. [PDF]

Medicine (Baltimore)
Li R, Hu K, Cui L, Sun S, Xie Y.
europepmc   +1 more source

Epidemiology of Metabolic Dysfunction–Associated Steatotic Liver Disease in South Asian Ethnicities: A Systematic Review and Meta‐Analysis

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aims People of South Asian ethnicities are at increased risk of metabolic syndrome, but the epidemiology of metabolic dysfunction–associated steatotic liver disease (MASLD) in this population remains poorly understood. This systematic review and meta‐analysis assesses the prevalence, cross‐sectional severity, and clinically ...
Michael James, Melanie Smuk, Naheeda Rahman, Georgia Black, William Alazawi   +4 more
wiley   +1 more source

A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese

, 2018
Huanhuan Yang, Guo‐Chong Chen, Chunli Song, Deming Li, Qinghua Ma, Guangliang Chen, Xinli Li   +6 more
openalex   +1 more source

Inflammatory and Immunological Basis of Periodontal Diseases

Journal of Periodontal Research, EarlyView.
The periodontal lesion emerges as an evolving immunological battlefield, where host–microbiome interactions, dysregulated immune responses, fragile resolution mechanisms, and inflammophilic dysbiosis converge to shift the balance from homeostasis to unrestrained tissue destruction.
Giacomo Baima, Marion Arce, Mario Romandini, Thomas Van Dyke   +3 more
wiley   +1 more source

Corrigendum to "Bone Turnover Markers in Adults with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis". [PDF]

Int J Endocrinol
europepmc   +1 more source

Corrigendum: Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease. [PDF]

Front Microbiol
Jiang H, Wang H, Guo Y, Zhu Y, Dai H, Liang C, Gao J.   +6 more
europepmc   +1 more source